Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials
Coronary Artery Bypass
Coronary Artery Disease
Percutaneous Coronary Intervention
Randomized Controlled Trials as Topic
In patients with multivessel coronary disease, CABG was found to be superior to DES-PCI by reducing the risk of mortality and subsequent myocardial infarction at the expense of a marginally increased risk of stroke.